Patent · US Active

Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin

US9096546B2 · kind B2 · utility

0Cited by

70References

21Claims

0Family size

Assignees

ALBANY MOLECULAR RESEARCH, INC. · US
Bristol-Myers Squibb Company · US

Inventors

Peter R. Guzzo · Niskayuna, US
Bruce F. Molino · Slingerlands, US
Wenge Cui · Clifton Park, US
Shuang Liu · Schenectady, US
Richard E. Olson · Wilmington, US
Larry Yet · Mobile, US

Key dates

Filing date	May 8, 2008
Grant date	Aug 4, 2015
Priority date	—
Expiry date	Apr 29, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepine derivative compounds of the present invention are represented by formulae 1(A-D) having the following structure: where the substituents X and R1-R8 are as defined herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.